A consensus statement on the gender perspective in lung cancer

• D. Isla ^[1] ; M. Majem ^[13] ; N. Viñolas ^[14] ; A. Artal ^[2] ; A. Blasco ^[3] ; E. Felip ^[15] ; P. Garrido ^[4] ; J. Remón ^[16] ; M. Baquedano ^[1] ; J. M. Borrás ^[5] ; M. Die Trill ^[17] ; R. García-Campelo ^[6] ; O. Juan ^[7] ; C. León ^[8] ; P. Lianes ^[16] ; F. López-Ríos ^[9] ; L. Molins ^[14] ; M. Á. Planchuelo ^[18] ; M. Cobo ^[10] ; L. Paz-Ares ^[11] ; J. M. Trigo ^[10] ; J. de Castro ^[12]
  1. [1] Hospital Clínico Universitario Lozano Blesa

     Hospital Clínico Universitario Lozano Blesa

     Zaragoza, España

     
  2. [2] Hospital Miguel Servet

     Hospital Miguel Servet

     Zaragoza, España

     
  3. [3] Hospital General Universitario de Valencia

     Hospital General Universitario de Valencia

     Valencia, España

     
  4. [4] Hospital Ramón y Cajal

     Hospital Ramón y Cajal

     Madrid, España

     
  5. [5] Universitat de Barcelona

     Universitat de Barcelona

     Barcelona, España

     
  6. [6] Complexo Hospitalario Universitario da Coruña

     Complexo Hospitalario Universitario da Coruña

     A Coruña, España

     
  7. [7] Hospital Universitario La Fe

     Hospital Universitario La Fe

     Valencia, España

     
  8. [8] Hospital de Terrassa

     Hospital de Terrassa

     Barcelona, España

     
  9. [9] Hospital Universitario HM Sanchinarro

     Hospital Universitario HM Sanchinarro

     Madrid, España

     
  10. [10] Hospital Universitario Virgen de la Victoria

      Hospital Universitario Virgen de la Victoria

      Málaga, España

      
  11. [11] Hospital Universitario 12 de Octubre

      Hospital Universitario 12 de Octubre

      Madrid, España

      
  12. [12] Hospital Universitario La Paz

      Hospital Universitario La Paz

      Madrid, España

      
  13. [13] Hospital Universitario Sant Pau, España
  14. [14] Hospital Clinic, Barcelona, España
  15. [15] Hospital Universitario Vall d’Hebron, España
  16. [16] Hospital Universitario Mataró, España
  17. [17] Atrium, Madrid, España
  18. [18] Consejería de Sanidad, Madrid, España

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 19, Nº. 5 (May 2017), 2017, págs. 527-535
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Lung cancer is the most common cancer globally and has the highest mortality. Although this disease is not associated with a particular gender, its incidence is rising among women, who are diagnosed at an increasingly younger age compared with men. One of the main reasons for this rise is women taking up smoking. However, many non-smoking women also develop this disease. Other risk factors implicated in the differential development of lung cancer in women are genetic predisposition, tumour histology and molecular profile. Proportionally more women than men with lung cancer have a mutation in the EGFR gene. This consensus statement reviews the available evidence about the epidemiological, biological, diagnostic, therapeutic, social and psychological aspects of lung cancer in women.